Menu

Close

  1. Yokohama-shi Top Page
  2. Municipal Government Information
  3. Public Relations, Public Information, News
  4. Press release
  5. Medical Care Bureau
  6. Press Release FY2023
  7. NTT x Yokohama Launched experimental project, a voluntary rehabilitation of patients with heart disease.

Here's the text.

NTT x Yokohama Launched experimental project, a voluntary rehabilitation of patients with heart disease.

Last update date May 10, 2023

Press release materials

May 10, 2023

Medical Care Bureau Cancer and Disease Control Division

Mieko Koga

Phone number: 045-671-2957

Fax: 045-664-3851

In Yokohama City, patients who have developed cardiovascular diseases such as myocardial infarction can continue their exercise even after the "heart rehabilitation * 1" conducted in insurance medical treatment, and work on continuing exercise. We work on enlightenment. NTT Communications Corporation, NTT Data Management Research Laboratories, Inc., and Yokohama City, will conduct a voluntary rehabilitation experimental project for heart disease patients utilizing "Mieru Rehabilitation" in Yokohama.
【※1】 Cardiac rehabilitation (partially modified from the website of the Japan Society of Heart Rehabilitation)
A comprehensive activity program (exercise therapy, learning activity / life guidance, counseling, etc.) to prevent cardiovascular disease from recurring or re-hospitalization. Multidisciplinary occupations such as doctors, physiotherapists, nurses, and pharmacists work together, and has the effect of re-hospitalization of heart failure patients and reducing the total mortality rate.

In order to open PDF files, you may need a separate PDF reader.
If you do not have it, you can download it free of charge from Adobe.
Get Adobe Acrobat Reader DCTo download Adobe Acrobat Reader DC

For inquiries to this page

Cancer and Disease Control Division, Medical Care Bureau Regional Medical Department

Phone: 045-671-2721

Phone: 045-671-2721

Fax: 045-664-3851

Email address: ir-gantaisaku@city.yokohama.jp

Return to the previous page

Page ID: 513-765-859

Menu

  • LINE
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • SmartNews